Nurse-conducted smoking cessation in patients with COPD, using nicotine sublingual tablets and behavioral support

Chest

Volumn 130, Issue 2, 2006, Pages 314-316

  Pbert, Lori ^a,b  

^a University of Massachusetts Medical School ^*

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE;

BEHAVIOR THERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; EDITORIAL; EVIDENCE BASED MEDICINE; FORCED EXPIRATORY VOLUME; HUMAN; NICOTINE REPLACEMENT THERAPY; NURSE; PATIENT COUNSELING; PRIORITY JOURNAL; SMOKING CESSATION;

EID: 33747623320     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.130.2.314     Document Type: Editorial

References (17)

1. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163:1256-1276
2. Roche N, Huchon GJ. Current issues in the management of chronic obstructive pulmonary diseases. Respirology 1997; 2:215-229
3. US Department ol Health and Human Services. The health consequences of smoking: chronic obstructive lung disease. Rockville, MD: Office on Smoking and Health, Department of Health and Human Services, 1984; Report No. (CDC) 8.416
4. Doll R, Peto R, Wheatley K, et al. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 1994; 309:901-911
5. Decramer M, Gosselink R, Bartsch P, et al. Effect of treatments on the progression of COPD: report of a workshop held in Leuven, 11-12 March 2004. Thorax 2005; 60:343-349
6. Burchfiel CM, Marcus EB, Curb JD, et al. Effects of smoking and smoking cessation on longitudinal decline in pulmonary function. Am J Respir Crit Care Med 1995; 151:1778-1785
7. Pelkonen M, Notkola IL, Tukiainen H, et al. Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study. Thorax 2001; 56:703-707
8. 1: the Lung Health Study. JAMA 1994; 272:1497-1505
9. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence: clinical practice guidelines. Rockville, MD: US Department of Health and Human Services, Public Health Service, 2000
10. van der Meer RM, Wagena EJ, Ostelo RJ, et al. Smoking cessation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (database online) Issue 1, 2006
11. Wagena EJ, van der Meer RM, Ostelo RJ, et al. The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: results from a systematic review. Respir Med 2004; 98:805-815
12. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease: American Thoracic Society. Am J Respir Crit Care Med 1995; 152:S77-S121
13. Jimenez-Ruiz CA, Masa F, Miravitlles M, et al. Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest 2001; 119:1365-1370
14. Tashkin D, Kanner R, Bailey W, et al. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet 2001; 357:1571-1575
15. Tonnesen P, Mikkelsen K, Bremann L. Nurse-conducted smoking cessation in patients with COPD, using nicotine sublingual tablets and behavioral support. Chest 2006; 130; 2:334-342
16. Silagy C, Lancaster T, Stead L, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev (database online) Issue 1, 2006
17. Monninkhof E, van der Valk P, van der Palen J, et al. The effect of a minimal contact smoking cessation programme in out-patients with chronic obstructive pulmonary disease: a pre-post-test study. Patient Educ Couns 2004; 52:231-236